Showing results (111-120 of 293) with videos related to

Sort By:
Pageof 30
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2009
Anti-CTLA-4 therapy results in higher CD4+ICOShi T cell frequency and IFN-gamma levels in both nonmalignant and malignant prostate tissuesHong Chen, Chrysoula I Liakou, Ashish Kamat, et al.
Carcinogenesis|August 14, 2019
Mitochondrial DNA copy number in peripheral blood leukocytes is associated with biochemical recurrence in prostate cancer patients in African AmericansJunfeng Xu, Wen-Shin Chang, Chia-Wen Tsai, et al.
Molecular & Cellular Proteomics : MCP|December 21, 2014
Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironmentYu-Chen Lee, Martina Srajer Gajdosik, Djuro Josic, et al.
International Journal of Cancer|March 5, 2014
Systemic GLIPR1-ΔTM protein as a novel therapeutic approach for prostate cancerTheodoros Karantanos, Ryuta Tanimoto, Kohei Edamura, et al.
Carcinogenesis|March 28, 2020
Genetic variants in epithelial-mesenchymal transition genes as predictors of clinical outcomes in localized prostate cancerYang Deng, Kunlin Xie, Christopher J Logothetis, et al.
Molecular Carcinogenesis|July 29, 2003
Prostate-specific antitumor activity by probasin promoter-directed p202 expressionYong Wen, Dipak Giri, Duen-Hwa Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancerYukiko Kiniwa, Yoshihiro Miyahara, Helen Y Wang, et al.
Molecular and Cellular Biology|April 25, 2002
mRTVP-1, a novel p53 target gene with proapoptotic activitiesChengzhen Ren, Likun Li, Alexei A Goltsov, et al.
Cardio-Oncology (London, England)|September 13, 2023
Cardiometabolic healthcare for men with prostate cancer: an MD Anderson Cancer Center experienceAndrew W Hahn, Whittney Thoman, Efstratios Koutroumpakis, et al.
The Prostate|April 2, 2011
Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: morphological, immunohistochemical, and gene expression profilesAna Aparicio, Vasiliki Tzelepi, John C Araujo, et al.
Pageof 30